In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos
The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July.
Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients
The ALS clinical trial landscape is characterised by a significant number of active trials and sponsors, including MediciNova's Ph3 with MN-166.
Cell and gene therapies are changing the way pharmaceutical organisations think about sample storage.
Editor's Picks
